Upper Gastrointestinal Bleeding Clinical Trial
Official title:
Local Side Effects of Transesophageal Echocardiography
Transesophageal echocardiography is commonly used during cardiac surgery. Complications of
transesophageal echocardiography are rare (1,2%), but are often underestimated and can lead
to unrecognized blood loss and site of infection.
This study wants to assess the mucosa of pharynx, upper larynx, esophagus and stomach prior
to and after echo probe insertion during cardiac surgery with endoscopy.
Transesophageal echocardiography is commonly used during cardiac surgery. Main reasons for
its use are the evaluation of cardiac function and valve morphology previous to and after
cardiac surgery.
Complications of transesophageal echocardiography are rare (1,2%). Described complications
may involve the gastrointestinal, cardiovascular or respiratory system.
The major complication of transesophageal echocardiography is local injury of the GI tract.
Only massive bleeding and perforation were reported, minor injuries are not noticed in the
early postoperative period but may play an important role, especially in patients discomfort,
source of minor unrecognized blood loss and site of infection. As oropharyngeal bacteria are
known to cause endocarditis and graft infection, this site of infection may be of special
interest in cardiac surgery.
Study objectives:
To assess the mucosa of pharynx, upper larynx, esophagus and stomach prior to and after TEE
probe insertion during cardiac surgery using flexible endoscopy.
Design:
Open, not randomized, observer blinded, pilot study. Inclusion criteria
- Planned cardiac surgery
- Age above 18 years
- Signed informed consent
- Clinical need for intraoperative use of transesophageal echocardiography Exclusion
criteria
- Recent gastrointestinal pathologies (3-6 months)
- Recent operations of the upper gastrointestinal tract (3-6 months)
- Subjects not able to understand study procedures
- No signed informed consent
- Contraindications for transesophageal echocardiography
After induction of anesthesia and insertion of all needed catheters (arterial catheter,
central venous catheter, bladder catheter, and pulmonary artery catheter, if indicated) an
expert physician will perform the endoscopy (Olympus; Hamburg, Germany) of pharynx,
esophagus, and stomach in order to exclude (respectively map) any alteration of the mucosa.
Immediately after endoscopy the transesophageal probe (6T, 6T-RS, 6Tc, 6Tc-RS Vivid GE; USA;
X7-2T, S7-2omni, Philips), covered with a special condom, will be inserted. The TOE probe
will remain 7-8 hours in the GI tract.
Two standard echocardiographic examinations are routinely performed during cardiac operation;
the first (prior to skin incision) is assigned as baseline evaluation of cardiac morphology
and function; the second (after weaning from cardiopulmonary bypass) is performed to check
the result of the surgical procedure respectively to determine cardiac function for
decision-making of medical treatment. A routine TEE - examination follows guidelines for
standard TEE views and examination workflow and includes a minimum of 11 views up to a
maximum of 28 views, depending on the type of pathology. Average time needed to perform a
standard TEE examination varies from 5-15minutes.
For these reasons the number of TEE views per examination, the length of each examination,
and the different probe positions (upper esophageal, mid esophageal, transgastric and deep
transgastric) during examination and the length of stay of the probe in each position will be
reported. As soon as the TEE probe has been removed the second endoscopy it will be performed
in the same order as the baseline endoscopy.
Possible lesions of the mucosa will be classified as described by Geene et al. (Greene 1999,
#9) as follows: erythema, edema, hematoma, mucosal erosion, petechiae, and perforation. In
particular pharynx, upper esophagus, mid esophagus, cardia, gastric fundus, und gastric body
will be examined.
The analysis of filmed examination will be performed by the endoscopist in a second time
off-line, in a blind manner.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02537353 -
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip
|
Phase 4 | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Suspended |
NCT03337256 -
Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy
|
N/A | |
Completed |
NCT04472364 -
HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
Recruiting |
NCT00414713 -
Transfusion Requirements in Gastrointestinal (GI) Bleeding
|
Phase 4 | |
Completed |
NCT03680950 -
Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System
|
N/A | |
Completed |
NCT05085405 -
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial
|
N/A | |
Recruiting |
NCT06077916 -
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
|
N/A | |
Recruiting |
NCT04902248 -
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT02446678 -
Use of PillCam ESO2 in Triaging Patients Present With Upper GIB
|
N/A | |
Completed |
NCT05631639 -
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
|
N/A | |
Completed |
NCT02978391 -
UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
|
N/A | |
Completed |
NCT00045799 -
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
|
Phase 3 | |
Recruiting |
NCT03090945 -
Pediatric Acute Gastrointestinal Bleeding Registry
|
||
Recruiting |
NCT06192355 -
Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
|
N/A | |
Recruiting |
NCT06297954 -
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
|
Phase 3 | |
Recruiting |
NCT03785080 -
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients
|
N/A | |
Completed |
NCT03667703 -
Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
|
Phase 4 | |
Terminated |
NCT02017379 -
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
|
N/A |